February 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Nuvation Bio Inc. (NYSE: NUVB) breached their fiduciary duties to ...
NEW YORK - Nuvation Bio Inc. (NYSE:NUVB), a biopharmaceutical company focused on oncology with a market capitalization of $777 million, has launched an Expanded Access Program (EAP) in the United ...
Nuvation Bio (NUVB) announced it has initiated an Expanded Access Program or EAP for taletrectinib in the U.S. for the treatment of patients ...
NEW YORK - Nuvation Bio Inc. (NYSE:NUVB), a biopharmaceutical company focused on oncology with a market capitalization of $777 million, has launched an Expanded Access Program (EAP) in the United ...
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded ...
NEW YORK, February 03, 2025--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has ...
Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company ...
Every investor in Nuvation Bio Inc. (NYSE:NUVB) should be aware of the most powerful shareholder groups. With 46% stake, institutions possess the maximum shares in the company. In other words ...
Every investor in Nuvation Bio Inc. (NYSE:NUVB) should be aware of the most powerful shareholder groups. With 46% stake, institutions possess the maximum shares in the company. In other words, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback